While these variants do not predict exact medication response, they can inform a more targeted clinical conversation with your provider about whether GLP-1 therapy aligns with your metabolic physiology
These effects are likely primarily mediated through actions in various regions of the brain involved in the regulation of appetite and food intake [18], as supported by preclinical studies [19,20,21,22], multiple human imaging studies [18], and the GLP-1R expression patterns in the human brain [9, 23]
marketing Signs You May Be Affected: You have purchased the Lunakai Pro GLP-1 Booster You bought the supplements because they were marketed as supporting GLP-1 production, weight loss, or appetite suppression The supplements did not produce the advertised effects The supplements produced adverse effects You would not have purchased the supplement if you had known the claims were not supported by reliable scientific or medical evidence If you have encountered these issues, we would like to hear from you
Review both before submitting your intake
As of March 2025, the U.S
Other pharmaceutical companies began developing their own GLP-1 drugs to improve upon Byetta
